Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMNB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,443
Award facts
- Contract value 100% obligated
- $30,442.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,442.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, contains no set-aside designation and represents one of numerous pharmaceutical supply orders issued to the contractor in recent months. The delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for Department of Defense pharmaceutical supply needs.
DMS Pharmaceutical Group's PPV-G GEN V contract, awarded on November 13, 2025, carries a $499.999 billion ceiling and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. Under this vehicle, the contractor supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support military healthcare facilities worldwide. The current delivery order exemplifies the company's established role as a critical pharmaceutical supplier within the federal military medical system, with the contractor's consistent performance on prior orders demonstrating capability to fulfill the diverse and specialized pharmaceutical requirements of Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26FEMNB?
SPE2DU26FEMNB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DU26FEMNB worth?
The government has obligated $30,443 on SPE2DU26FEMNB.
Is contract SPE2DU26FEMNB an order under another contract?
Yes. SPE2DU26FEMNB is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNB competed?
The extent of competition for SPE2DU26FEMNB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award